1. Exploring structural features of EGFR–HER2 dual inhibitors as anti-cancer agents using G-QSAR approach. (4th May 2019) Authors: Fatima, Shehnaz; Agarwal, Subhash Mohan Journal: Journal of receptor and signal transduction research Issue: Volume 39:Number 3(2019) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In-Silico molecular screening of natural compounds as a potential therapeutic inhibitor for Methicillin-resistant Staphylococcus aureus inhibition. (1st April 2023) Authors: Nandhini, Palanichamy; Gupta, Prashant Kr; Mahapatra, Arun Kumar; Das, Agneesh Pratim; Agarwal, Subhash Mohan; Mickymaray, Suresh; Alothaim, Abdulaziz S.; Rajan, Mariappan Journal: Chemico-biological interactions Issue: Volume 374(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Insight into structural requirements of antiamoebic flavonoids: 3D‐QSAR and G‐QSAR studies. (26th June 2018) Authors: Fatima, Shehnaz; Gupta, Payal; Agarwal, Subhash Mohan Journal: Chemical biology & drug design Issue: Volume 92:Number 4(2018) Page Start: 1743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. NPred: QSAR classification model for identifying plant based naturally occurring anti-cancerous inhibitors. Issue 55 (18th May 2016) Authors: Dhiman, Kanika; Agarwal, Subhash Mohan Journal: RSC advances Issue: Volume 6:Issue 55(2016) Page Start: 49395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetic profiling of anticancer phytocompounds using computational approach. Issue 6 (18th April 2018) Authors: Sharma, Ashish; Sharma, Shilpa; Gupta, Mansi; Fatima, Shehnaz; Saini, Ravi; Agarwal, Subhash Mohan Journal: Phytochemical analysis Issue: Volume 29:Issue 6(2018) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. QSAR of clinically important EGFR mutant L858R/T790M pyridinylimidazole inhibitors. (15th April 2019) Authors: Fatima, Shehnaz; Pal, Divyani; Agarwal, Subhash Mohan Journal: Chemical biology & drug design Issue: Volume 94:Number 1(2019) Page Start: 1306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Structure guided design and binding analysis of EGFR inhibiting analogues of erlotinib and AEE788 using ensemble docking, molecular dynamics and MM-GBSA. Issue 70 (12th July 2016) Authors: Sharma, Vishnu K.; Nandekar, Prajwal P.; Sangamwar, Abhay; Pérez-Sánchez, Horacio; Agarwal, Subhash Mohan Journal: RSC advances Issue: Volume 6:Issue 70(2016) Page Start: 65725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. TMLRpred: A machine learning classification model to distinguish reversible EGFR double mutant inhibitors. (15th October 2020) Authors: Saini, Ravi; Fatima, Shehnaz; Agarwal, Subhash Mohan Journal: Chemical biology & drug design Issue: Volume 96:Number 3(2020) Page Start: 921 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Unraveling structural requirements of amino-pyrimidine T790M/L858R double mutant EGFR inhibitors: 2D and 3D QSAR study. (4th July 2018) Authors: Fatima, Shehnaz; Agarwal, Subhash Mohan Journal: Journal of receptor and signal transduction research Issue: Volume 38:Number 4(2018) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. VOCC: a database of volatile organic compounds in cancer. Issue 115 (9th December 2016) Authors: Agarwal, Subhash Mohan; Sharma, Mansi; Fatima, Shehnaz Journal: RSC advances Issue: Volume 6:Issue 115(2016) Page Start: 114783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗